Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Comment

Pharmacogenomics arrives

Gregory A Petsko

Author Affiliations

Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454-9110, USA

Genome Biology 2004, 5:108  doi:10.1186/gb-2004-5-6-108

Published: 28 May 2004

We've had the human genome sequence for a little while now, and it looks as though we're still some way off being able to exclude from most clinical trials those people who will probably suffer side effects.